Amarantus Bioscience Holdings Inc (AMBS)

[GreenMan]

"The corporate presentation at Biotech Showcase 2013 will be made the day after the presentation of Parkinson’s neurorestoration animal data by CSO Dr. John Commissiong and concurrent scientific overview of the broader MANF opportunity by Dr. Joseph Rubinfeld, an Advisor to Amarantus."

If Dr. Rubinfeld is going to present on the "broader MANF opportunity", then the phase I animal study to be previously presented by Dr. Commissiong cannot be anything but promising.

If we were talking about any other subject where the premises required such a logical conclusion, no one here would disagree. In other words, if we had absolutely no connection to AMBS and were watching Sherlock, and he came to the conclusion that AMBS presentations will highly likely be favorable to MANF based on the observations so far, everyone here would agree.

The only question for me is how promising for MANF will the presentations support such that capital wants in and supports the next phases of testing. That's what's on the table here folks not non-starter arguments about unsubstantiated dilutions, or rats, or that Rubinfeld only bought a million shares of AMBS (instead of?) or reverse splits.